A new class of drugs can now remove the protein behind Alzheimer's disease from the brain. But it doesn't restore memory. It doesn't cure the disease. And not everyone qualifies. So what does it actually do and who is it for?

Dr. David Reuben and Dr. Alejandra Sanchez Lopez walk through everything families and patients need to know before considering anti-amyloid therapy from eligibility criteria and side effect risks to what the clinical trial data really means in plain language.

RESOURCES
Register For Intensive Course

UCLA Geriatric Medicine Board Review Course — September 2025 https://web.cvent.com/event/8180d94f-f261-4184-af2b-8733d348cedf/websitePage:b72f2e65-ac9a-4e42-9aec-c6ebbcf735ba

Aging Now Instagram

https://www.instagram.com/agingnowpodcast

UCLA Geriatrics Instagram:

https://www.instagram.com/uclageriatrics/

UCLA Division of Geriatrics: https://www.uclahealth.org/departments/medicine/geriatrics/education

FEATURED PHYSICIANS

Dr. Alejandro Sanchez Lopez
Neurologist | UCLA Health

Dr. David Reuben
Geriatrician | UCLA Alzheimer's and Dementia Care Program

The information shared in this podcast is for educational purposes only and does not constitute medical advice. Please consult a qualified healthcare provider for guidance specific to your situation